Maffei, D;
Giganti, F;
Moore, CM;
(2023)
Seminar: Revisiting the value of PSA-based prostate cancer screening Essay No 5: Should men undergo MRI before prostate biopsy? (Pro).
Urologic Oncology: Seminars and Original Investigations
, 41
(2)
pp. 88-91.
10.1016/j.urolonc.2022.04.016.
Preview |
Text
Moore_Revisiting the value of PSA based screening.pdf Download (226kB) | Preview |
Abstract
Prostate cancer is the commonest cancer in men in Europe and many countries worldwide, and the second commonest cause of cancer-related death. A screening programme to detect clinically relevant prostate cancer at a time when it can be cured, without burdensome overdiagnosis and subsequent overtreatment, is a laudable goal. We will set out the advances in MRI imaging, and the progress in MRI for men prior to biopsy, discussing whether MRI has a place before biopsy, or as a primary screening tool, in a modern approach to prostate cancer screening.
Archive Staff Only
 |
View Item |
